Unity Biotechnology, Inc.
UBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16,430 | $28,512 | $26,015 | $81,491 |
| - Cash | $7,580 | $19,803 | $12,736 | $32,905 |
| + Debt | $23,539 | $26,990 | $50,458 | $56,899 |
| Enterprise Value | $32,389 | $35,699 | $63,737 | $105,485 |
| Revenue | $0 | $0 | $236 | $4,784 |
| % Growth | – | -100% | -95.1% | – |
| Gross Profit | -$867 | -$19,699 | -$1,944 | $1,904 |
| % Margin | – | – | -823.7% | 39.8% |
| EBITDA | -$25,123 | -$37,283 | -$38,731 | -$54,668 |
| % Margin | – | – | -16,411.4% | -1,142.7% |
| Net Income | -$25,990 | -$39,860 | -$44,469 | -$60,725 |
| % Margin | – | – | -18,842.8% | -1,269.3% |
| EPS Diluted | -1.54 | -2.7 | -4.68 | -10.9 |
| % Growth | 43% | 42.3% | 57.1% | – |
| Operating Cash Flow | -$20,865 | -$38,651 | -$51,029 | -$45,060 |
| Capital Expenditures | $0 | -$11 | -$96 | -$195 |
| Free Cash Flow | -$20,865 | -$37,099 | -$51,125 | -$45,255 |